Quote:

---

"We note that under CLIA, only one laboratory facility can run a Laboratory Developed Test, so if once LymPro is cleared under CLIA ICON has meaningful upside as the contracted lab to run the test for Amarantus."

"We believe this could turn into a full commercialization partnership for Amarantus in time. With this agreement, Amarantus also gain access to a global distribution network for LymPro, including central laboratories in Europe, Singapore, India and China that will allow LymPro to enter these new markets seamlessly through an already established distribution framework. In addition, ICON is also providing to Amarantus consulting support for eltoprazine and MANF."

---